Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Blood and sperm tests needed to identify HIV carriers

This article was originally published in Clinica

Executive Summary

Men treated with anti-HIV drugs continue to secrete the virus in their semen and could spread resistant viruses through sexual intercourse, a Swiss-American study has revealed. As a result, doctors will need to test the semen of male HIV carriers for the virus as well their blood, to ensure that all traces of virus have been eliminated, say the study's leaders Dr Pietro Vernazza and Dr Joseph Eron, in the October 22 issue of the journal AIDS.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT082345

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel